title: Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination.
abstract: Premature ovarian failure in a well adolescent is a rare event. Its occurrence raises important questions about causation, which may signal other systemic concerns. This patient presented with amenorrhoea after identifying a change from her regular cycle to irregular and scant periods following vaccinations against human papillomavirus. She declined the oral contraceptives initially prescribed for amenorrhoea. The diagnostic tasks were to determine the reason for her secondary amenorrhoea and then to investigate for possible causes of the premature ovarian failure identified. Although the cause is unknown in 90% of cases, the remaining chief identifiable causes of this condition were excluded. Premature ovarian failure was then notified as a possible adverse event following this vaccination. The young woman was counselled regarding preservation of bone density, reproductive implications and relevant follow-up. This event could hold potential implications for population health and prompts further inquiry.
authors.affiliation: Department of General Practice, North Bellingen Medical Services, Bellingen, Australia. dradford@wirefree.net.au
authors.forename: Deirdre Therese
authors.initials: DT
authors.lastname: Little
authors.forename: Harvey Rodrick Grenville
authors.initials: HR
authors.lastname: Ward
mesh_terms: D000293:Adolescent; D003937:Diagnosis, Differential; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D053918:Papillomavirus Vaccines / Q000009:adverse effects*; D016649:Primary Ovarian Insufficiency / Q000175:diagnosis / Q000209:etiology*
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines